Open for recruitment
Trial summary
The intention of the study is to demonstrate superiority of AZD5305 + physician’s choice NHA relative to placebo + physician’s choice NHA by assessment of radiographic progression-free survival (rPFS) in participants with mCSPC.
Trial details
Short title
EvoPAR-Prostate01 / D9723C00001
Diagnosis
Prostate cancer
Type of treatment
Medical Oncology
Phase
III
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.